IDEXX Laboratories Inc. (Nasdaq: IDXX) on Thursday posted third-quarter results that beat market expectations amid a strong performance in its pet diagnostics business.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing reported Q3 earnings of $1.69 per diluted share, or 27 cents a share above a consensus forecast reported by financial news site Seeking Alpha.

Compared to a year ago, earnings per share were 36% higher on a reported basis and 47% higher on a comparable currency basis. Read more